KLOW (80 mg Vial) Dosage Protocol

Quickstart Highlights

KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair^[1]^[2]. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing^[3]^[4]. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling^[5]^[6]. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration^[7]^[8]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water → ~26.7 mg/mL total concentration.

Component concentrations: TB-500, BPC-157, KPV each at ~3.33 mg/mL; GHK-Cu at ~16.7 mg/mL.

Easy measuring: At 26.7 mg/mL total, 1 unit = 0.01 mL ≈ 267 mcg total peptide on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~26.7 mg/mL Total)

This multi-peptide blend provides synergistic regenerative, anti-inflammatory, and tissue-repair support. The following titration schedule allows gradual introduction of each component.

Week	Daily Dose (per component)	Units (per injection) (mL)
Weeks 1–2	TB-500: 250 mcg \| BPC-157: 250 mcg \| KPV: 250 mcg \| GHK-Cu: 1.25 mg	7.5 units (0.075 mL)
Weeks 3–4	TB-500: 500 mcg \| BPC-157: 500 mcg \| KPV: 500 mcg \| GHK-Cu: 2.5 mg	15 units (0.15 mL)
Weeks 5–8	TB-500: 750 mcg \| BPC-157: 750 mcg \| KPV: 750 mcg \| GHK-Cu: 3.75 mg	22.5 units (0.225 mL)
Weeks 9–12 (Maintenance)	TB-500: 500 mcg \| BPC-157: 500 mcg \| KPV: 500 mcg \| GHK-Cu: 2.5 mg	15 units (0.15 mL)

Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to maintain measurable volumes. For ≤10-unit (≤0.10 mL) administrations during initial weeks, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Syringe Math Reference

With 3.0 mL reconstitution volume and 80 mg total peptide:

Total concentration: 26.67 mg/mL (26,667 mcg/mL)

TB-500: 3.33 mg/mL → 33.3 mcg per unit

BPC-157: 3.33 mg/mL → 33.3 mcg per unit

KPV: 3.33 mg/mL → 33.3 mcg per unit

GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit

1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (KLOW, 80 mg each):

8 weeks ≈ 3 vials
12 weeks ≈ 4 vials
16 weeks ≈ 5 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (3 vials): 9 mL → 1 × 10 mL bottle
12 weeks (4 vials): 12 mL → 2 × 10 mL bottles
16 weeks (5 vials): 15 mL → 2 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100-count boxes
12 weeks: 168 swabs → recommend 2 × 100-count boxes
16 weeks: 224 swabs → recommend 3 × 100-count boxes

View Supplier

Protocol Overview

Concise summary of the once-daily regimen.

Goal: Support tissue repair, reduce inflammation, and promote regeneration through synergistic peptide action^[1]^[3]^[5]^[7].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).

Dose Range: Gradual titration from low to moderate doses based on individual response.

Reconstitution: 3.0 mL per 80 mg vial (~26.7 mg/mL total) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.